Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity
- 6 December 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 300 (1) , 241-246
- https://doi.org/10.1016/s0006-291x(02)02787-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- TAK1-dependent Activation of AP-1 and c-Jun N-terminal Kinase by Receptor Activator of NF-κBBMB Reports, 2002
- Cadmium blocks hypoxia‐inducible factor (HIF)‐1‐mediated response to hypoxia by stimulating the proteasome‐dependent degradation of HIF‐1αEuropean Journal of Biochemistry, 2000
- Redox-Regulated Recruitment of the Transcriptional Coactivators CREB-Binding Protein and SRC-1 to Hypoxia-Inducible Factor 1αMolecular and Cellular Biology, 2000
- Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical CarcinomaGynecologic Oncology, 1998
- FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase InhibitorExperimental Cell Research, 1998
- What's Up and Down with Histone Deacetylation and Transcription?Cell, 1997
- Histone Acetylation and Chromatin Assembly: A Single Escort, Multiple Dances?Cell, 1996
- FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice.The Journal of Antibiotics, 1994
- Alternative chromatin structure at CpG islandsCell, 1990
- Affinity chromatographic purification of nucleosomes containing transcriptionally active DNA sequencesJournal of Molecular Biology, 1987